# Indocyanine Green Fluoroscopy and SPY Angiography for the Assessment of Lymphatic Structure in Breast Cancer Patients at Risk for Breast Cancer-Related Lymphedema

> **NCT06672224** · NA · WITHDRAWN · sponsor: **City of Hope Medical Center**

## Conditions studied

- Breast Cancer-Related Lymphedema
- Breast Carcinoma

## Interventions

- **PROCEDURE:** Fluid Therapy
- **DRUG:** Indocyanine Green
- **OTHER:** Questionnaire Administration
- **OTHER:** Research or Clinical Assessment Tool
- **PROCEDURE:** SPY Elite Fluorescence Imaging
- **OTHER:** Survey Administration

## Key facts

- **NCT ID:** NCT06672224
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-08-14
- **Primary completion:** 2026-08-14
- **Final completion:** 2026-08-14
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** low accrual
- **Last updated:** 2025-09-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06672224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06672224, "Indocyanine Green Fluoroscopy and SPY Angiography for the Assessment of Lymphatic Structure in Breast Cancer Patients at Risk for Breast Cancer-Related Lymphedema". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06672224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
